Core Insights - The stock of Maide Medical (688310) closed at 20.9 yuan on October 24, 2025, with a 1.36% increase and a trading volume of 19,500 lots, amounting to a total transaction value of 40.54 million yuan [1] Financial Performance - For the first half of 2025, Maide Medical reported a main revenue of 141 million yuan, a year-on-year decrease of 14.75% - The net profit attributable to shareholders was 6.0451 million yuan, down 38.81% year-on-year - The non-recurring net profit was -2.5149 million yuan, a decline of 135.52% year-on-year - In Q2 2025, the company achieved a single-quarter main revenue of 101 million yuan, an increase of 10.58% year-on-year - The single-quarter net profit attributable to shareholders was 16.8424 million yuan, a significant increase of 2759.64% year-on-year - The single-quarter non-recurring net profit was 11.8767 million yuan, up 923.08% year-on-year [3] Market Position - Maide Medical's total market capitalization is 3.474 billion yuan, compared to the industry average of 7.749 billion yuan, ranking 188 out of 268 in the specialized equipment industry - The company's net assets stand at 828 million yuan, with an industry average of 2.253 billion yuan, ranking 200 out of 268 - The net profit of 6.0451 million yuan places the company at 193 out of 268 in the industry, with a price-to-earnings ratio of 287.34, significantly higher than the industry average of 51.37, ranking 191 out of 268 - The price-to-book ratio is 4.34, compared to the industry average of 3.97, ranking 169 out of 268 - The gross margin is 38.93%, above the industry average of 27.83%, ranking 43 out of 268 - The net margin is -1.29%, below the industry average of 0.66%, ranking 215 out of 268 - The return on equity (ROE) is 0.76%, compared to the industry average of 2.21%, ranking 190 out of 268 [3] Investment Sentiment - In the last 90 days, one institution has given a rating of "buy" for Maide Medical [4]
股票行情快报:迈得医疗(688310)10月24日主力资金净买入461.19万元